BNTX · PEAD ↓ 52

BioNTech reported Q1 2026 EPS of €-1.95 on 2026-05-11, beating the €-2.03 consensus by €0.08 (+3.9%); year-over-year comparison is unavailable.

Print-day reaction was -0.83% versus the prior close — a muted, slightly negative response despite the EPS beat, suggesting the market found little incremental positive surprise in the headline. The overnight gap to the T+1 open was flat at 0.0%, indicating neither conviction nor relief after the close. Over the following two sessions the stock drifted an additional -1.78%, extending the softness with no recovery impulse. Cumulative abnormal return of -3.70% versus SPY.US over the three-day window puts this firmly in PEAD short territory; the documented drift pattern holds the read through 2026-08-06.